Small molecules targeting p53 to improve antitumor therapy.

Area of Science:

• Oncology
• Molecular Biology
• Drug Discovery

Background:

• The p53 protein is a critical tumor suppressor.
• Dysregulation of p53 is common in many cancers.
• Targeting p53 offers a novel therapeutic strategy.

Purpose of the Study:

• To explore the therapeutic potential of small molecules targeting p53.
• To review agents that modulate p53 activity (wild-type and mutant).
• To assess the utility of p53 inhibitors in cancer treatment.

Main Methods:

• Review of preclinical data on p53 modulators.
• Analysis of small molecules activating wild-type p53.
• Evaluation of agents reactivating mutant p53.
• Investigation of p53 function inhibitors.

Main Results:

• Small molecules targeting p53 are an emerging class of anticancer agents.
• These modulators include activators of wild-type p53 and reactivators of mutant p53.
• Inhibitors of p53 functions are also being developed.

Conclusions:

• Small molecule p53 modulators hold significant therapeutic potential.
• Preclinical evidence supports combining p53-targeting agents with conventional therapies.
• Further research into p53-targeted therapies could advance cancer treatment.